JETEMA, Co., Ltd. (216080.KQ)

JETEMA, Co., Ltd. (216080.KQ) — VMCI valuation read

Composite valuation read on 216080.KQ: VMCI 35/100 against a Healthcare sector median of 50. The 15-point below-median print is the headline number for JETEMA, Co., Ltd., and at the mid-cap tier it reflects how the five pillars combine into a single decision-grade score.

Trailing 30-day insider activity for 216080.KQ: nothing material on SEC EDGAR. With the Form 4 channel quiet, the price-vs-DCF gap and the trailing margin trend carry more weight in the active read.

**Investor frame.** Value, quality, risk in three lines on 216080.KQ: 216080.KQ trades at 19.0x earnings, 6% above the Healthcare median of 18.0x; ROIC of 13.0% sits 3.0pp above the Healthcare median (10.0%); net debt to EBITDA of -1.3x leaves covenant headroom. EV/EBITDA at 14.0x versus 12.0x for Healthcare closes the value frame.

216080.KQ rose 1.7% over the trailing 7 days, with a -12.5% read on a 30-day basis.